Q3 2017 EPS Estimates for Endo International PLC (ENDP) Lifted by Oppenheimer Holdings

Endo International PLC (NASDAQ:ENDP) (TSE:ENL) – Investment analysts at Oppenheimer Holdings lifted their Q3 2017 earnings estimates for shares of Endo International PLC in a research note issued to investors on Monday. Oppenheimer Holdings analyst D. Archila now anticipates that the company will earn $0.69 per share for the quarter, up from their prior forecast of $0.65. Oppenheimer Holdings currently has a “Hold” rating on the stock. Oppenheimer Holdings also issued estimates for Endo International PLC’s Q3 2018 earnings at $0.67 EPS, Q4 2018 earnings at $0.71 EPS, FY2018 earnings at $2.71 EPS and FY2019 earnings at $3.20 EPS.

ENDP has been the subject of a number of other research reports. William Blair restated a “market perform” rating on shares of Endo International PLC in a research note on Wednesday, June 14th. BidaskClub lowered Endo International PLC from a “hold” rating to a “sell” rating in a research note on Thursday, June 15th. Cantor Fitzgerald assumed coverage on Endo International PLC in a report on Friday, June 16th. They set a “neutral” rating and a $12.00 target price on the stock. Guggenheim assumed coverage on Endo International PLC in a report on Saturday, June 17th. They set a “hold” rating and a $12.00 target price on the stock. Finally, Deutsche Bank AG reduced their target price on Endo International PLC from $18.00 to $15.00 and set a “buy” rating on the stock in a report on Friday, July 7th. Three research analysts have rated the stock with a sell rating, fifteen have given a hold rating and six have given a buy rating to the company. Endo International PLC presently has a consensus rating of “Hold” and a consensus price target of $12.64.

TRADEMARK VIOLATION WARNING: This story was originally posted by Markets Daily and is the sole property of of Markets Daily. If you are accessing this story on another website, it was illegally copied and reposted in violation of U.S. & international copyright & trademark legislation. The correct version of this story can be viewed at https://www.themarketsdaily.com/2017/10/12/q3-2017-eps-estimates-for-endo-international-plc-endp-lifted-by-oppenheimer-holdings.html.

Shares of Endo International PLC (NASDAQ:ENDP) opened at 8.98 on Thursday. Endo International PLC has a 1-year low of $7.41 and a 1-year high of $21.87. The company’s 50-day moving average price is $8.70 and its 200 day moving average price is $10.59. The stock’s market cap is $2.01 billion.

Endo International PLC (NASDAQ:ENDP) (TSE:ENL) last posted its earnings results on Tuesday, August 8th. The company reported $0.93 earnings per share for the quarter, topping the consensus estimate of $0.74 by $0.19. The firm had revenue of $875.73 million during the quarter, compared to analysts’ expectations of $832.66 million. Endo International PLC had a positive return on equity of 37.58% and a negative net margin of 126.93%. The firm’s revenue was down 4.9% compared to the same quarter last year. During the same quarter in the previous year, the business earned $0.86 earnings per share.

Several hedge funds have recently modified their holdings of the company. Piedmont Investment Advisors LLC increased its position in shares of Endo International PLC by 43.4% during the 2nd quarter. Piedmont Investment Advisors LLC now owns 59,211 shares of the company’s stock valued at $661,000 after purchasing an additional 17,928 shares during the period. Nomura Holdings Inc. acquired a new position in shares of Endo International PLC during the 2nd quarter valued at $745,000. Flinton Capital Management LLC increased its position in shares of Endo International PLC by 64.4% during the 2nd quarter. Flinton Capital Management LLC now owns 20,400 shares of the company’s stock valued at $228,000 after purchasing an additional 7,990 shares during the period. Bank of Hawaii acquired a new position in shares of Endo International PLC during the 2nd quarter valued at $180,000. Finally, Parametric Portfolio Associates LLC increased its position in shares of Endo International PLC by 18.7% during the 2nd quarter. Parametric Portfolio Associates LLC now owns 398,099 shares of the company’s stock valued at $4,447,000 after purchasing an additional 62,822 shares during the period. Institutional investors own 90.71% of the company’s stock.

In other news, CEO Paul Campanelli purchased 6,500 shares of the stock in a transaction dated Monday, August 14th. The shares were bought at an average cost of $7.71 per share, for a total transaction of $50,115.00. Following the transaction, the chief executive officer now owns 213,620 shares in the company, valued at $1,647,010.20. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, COO Terrance J. Coughlin purchased 20,000 shares of the stock in a transaction dated Thursday, August 10th. The shares were purchased at an average price of $7.70 per share, for a total transaction of $154,000.00. Following the completion of the transaction, the chief operating officer now owns 181,369 shares in the company, valued at approximately $1,396,541.30. The disclosure for this purchase can be found here. Over the last 90 days, insiders purchased 36,000 shares of company stock worth $279,460. 0.50% of the stock is owned by insiders.

About Endo International PLC

Endo International PLC, formerly Endo Health Solutions Inc is a specialty healthcare solutions company focused on branded and generic pharmaceuticals, devices and services. The Company has a portfolio of branded pharmaceuticals that includes brands, such as Lidoderm, Opana ER, Voltaren Gel, Percocet, Frova, Supprelin LA, Vantas, Valstar and Fortesta Gel.

Earnings History and Estimates for Endo International PLC (NASDAQ:ENDP)

Receive News & Ratings for Endo International PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Endo International PLC and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply